This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bruton’s tyrosine kinase
Chimeric antigen receptor T cell
Canadian Cancer Immunotherapy Consortium
Clear cell renal cell carcinoma
Digital polymerase chain reaction
Institut National de la Santé et de la Recherche Médicale
Janus kinase 3
John Cunningham virus
Lysosomal-associated membrane protein
Lymphocyte-specific protein tyrosine kinase
Myeloid-derived suppressor cells
Non-small cell lung carcinoma
T cell receptor
Tertiary lymphoid structures
Regulatory T cell
Virus-specific T cell
Varicella zoster virus
Cellular homolog of the Yamaguchi sarcoma virus oncogene
Conflict of interest
The authors declare no conflicts of interest. Connie Krawczyk participated in the organization of this CCIC meeting as coordinator of knowledge dissemination and outreach.
Jeanette E. Boudreau, Maartje C.A. Wouters and Connie M. Krawczyk have equally contributed to this work.
About this article
Cite this article
Boudreau, J.E., Wouters, M.C.A. & Krawczyk, C.M. 8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada. Cancer Immunol Immunother 65, 235–241 (2016). https://doi.org/10.1007/s00262-015-1785-2
- Cancer microenvironment
- Checkpoint therapies
- Monoclonal antibody therapy
- Cancer genomics
- Adoptive T cell therapy